Stocks · Health care · Biological Products, (No Diagnostic Substances)

Amgen

AMGN Clue Score50

United States Fiscal year ends December CIK 0000318154 Results filed 3 Nov 2026

Add to watchlist

What the insiders did Net selling

By person

22 insiders · 15 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Esteban Santos

EVP, Operations

—

$20.77M (2) scheduled

−$20.77M

82,847

0.0153%

$34.50M

+14.9%

Nancy A. Grygiel

SVP & CCO

—

$2.65M (5) scheduled

−$2.65M

7,340

0.0014%

$3.06M

−17.6%

Murdo Gordon

EVP, Global Commercial Ops

—

$2.32M (1)

−$2.32M

51,222

0.0095%

$21.33M

−4.4%

Rachna Khosla

SVP, Business Development

—

$1.65M (3)

−$1.65M

6,404

0.0012%

$2.67M

−24.8%

Derek Miller

SVP, Human Resources

—

$1.57M (2) scheduled

−$1.57M

12,462

0.0023%

$5.19M

+35.3%

Matthew C. Busch

VP, Finance & CAO

—

$375.79K (1)

−$375.79K

5,080

0.0009%

$2.12M

+4.7%

Robert A Bradway

Chairman, CEO and President

—

—

—

595,160

0.1101%

$247.84M

−2.8%

Peter H. Griffith

EVP & CFO

—

—

—

50,150

0.0093%

$20.88M

+36.3%

David M Reese

EVP & Chief Technology Officer

—

—

—

42,256

0.0078%

$17.60M

−32.6%

Jonathan P Graham

EVP & Gen. Counsel & Sec.

—

—

—

39,712

0.0073%

$16.54M

+10.6%

James E. Bradner

EVP, Research and Development

—

—

—

30,016

0.0056%

$12.50M

+10.8%

Robert Eckert

Director

—

—

—

26,251

0.0049%

$10.93M

+5.9%

Tyler Jacks

Director

—

—

—

18,284

0.0034%

$7.61M

+8.8%

Ellen Jamison Kullman

Director

—

—

—

14,536

0.0027%

$6.05M

+11.3%

Greg C. Garland

Director

—

—

—

13,848

0.0026%

$5.77M

+11.9%

Charles M Holley

Director

—

—

—

12,990

0.0024%

$5.41M

+21.2%

Brian Druker

Director

—

—

—

8,391

0.0016%

$3.49M

+21.3%

Wanda M Austin

Director

—

—

—

8,018

0.0015%

$3.34M

+22.5%

Omar Ishrak

Director

—

—

—

7,486

0.0014%

$3.12M

+39.9%

Michael Drake V

Director

—

—

—

5,876

0.0011%

$2.45M

+55.1%

Amy E Miles

Director

—

—

—

5,640

0.0010%

$2.35M

+35.4%

Mary E. Klotman

Director

—

—

—

2,211

0.0004%

$920.72K

+200.0%